KLK3 and posterior cortical atrophy: The MET panel showed a higher diagnostic performance than the PSA in differentiating PCa from control patients [AUC (MET vs. PSA): 0.823 ± 0.046 vs. 0.712 ± 0.057, p<0.001; Figure 2].